Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,882
archived clinical trials in
Obesity Weight Loss

Mobile App With Patient Financial Incentives for Adherence to Heart Failure Medications & Daily Self-Weighing
Randomized Controlled Trial of a Mobile App With Patient Financial Incentives for Tracking and Improving Adherence to Medications & Daily Self-Weighing to Reduce Heart Failure Readmissions
Status: Enrolling
Updated:  12/31/1969
University Medical Center of Princeton at Plainsboro
mi
from
Plainsboro, NJ
Mobile App With Patient Financial Incentives for Adherence to Heart Failure Medications & Daily Self-Weighing
Randomized Controlled Trial of a Mobile App With Patient Financial Incentives for Tracking and Improving Adherence to Medications & Daily Self-Weighing to Reduce Heart Failure Readmissions
Status: Enrolling
Updated: 12/31/1969
University Medical Center of Princeton at Plainsboro
mi
from
Plainsboro, NJ
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Jacksonville, FL
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Plantation, FL
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Plantation, FL
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Chicago, IL
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Greensboro, NC
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Salisbury, NC
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Salisbury, NC
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Wadsworth, OH
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Wadsworth, OH
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Philadelphia, PA
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Charleston, SC
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Arlington, VA
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Arlington, VA
Click here to add this to my saved trials
Gamification and Energetic Behavior Changes
Gamification and Energetic Behavior Changes in Adolescent-Parent Dyads With Obesity
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Gamification and Energetic Behavior Changes
Gamification and Energetic Behavior Changes in Adolescent-Parent Dyads With Obesity
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Status: Enrolling
Updated:  12/31/1969
Duke University - with Piedmont Health Services, Inc.
mi
from
Durham, NC
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary Care
Status: Enrolling
Updated: 12/31/1969
Duke University - with Piedmont Health Services, Inc.
mi
from
Durham, NC
Click here to add this to my saved trials
First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
A Randomised, Double-blinded, Single-dose, Dose-escalation, First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
A Randomised, Double-blinded, Single-dose, Dose-escalation, First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Ellner Bariatric
mi
from
San Diego, CA
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Ellner Bariatric
mi
from
San Diego, CA
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Digestive Health Center / Gastroroenterology Associates
mi
from
Baton Rouge, LA
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Digestive Health Center / Gastroroenterology Associates
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Surgical Specialists of Louisiana
mi
from
Metairie, LA
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Surgical Specialists of Louisiana
mi
from
Metairie, LA
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Allure Medical Spa
mi
from
Mount Clemens, MI
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Allure Medical Spa
mi
from
Mount Clemens, MI
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Center for Metabolic & Bariatric Surgery
mi
from
Cincinnati, OH
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Center for Metabolic & Bariatric Surgery
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Louisville Surgical Associates
mi
from
Louisville, KY
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Louisville Surgical Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Sun Coast Bariactrics
mi
from
Saint Petersburg, FL
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Sun Coast Bariactrics
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Metroeast Endoscopic Surgery Center
mi
from
Fairview Heights, IL
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Metroeast Endoscopic Surgery Center
mi
from
Fairview Heights, IL
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Dr. Keith's Wellness Options
mi
from
Norman, OK
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Dr. Keith's Wellness Options
mi
from
Norman, OK
Click here to add this to my saved trials
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated:  12/31/1969
Applied Research Center of Arkansas
mi
from
Little Rock, AR
ORBERA™ Post-Approval Study
ORBERA™ Post-Approval Study
Status: Enrolling
Updated: 12/31/1969
Applied Research Center of Arkansas
mi
from
Little Rock, AR
Click here to add this to my saved trials
Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment
Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment
Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
The Effect of Nutrient Intake on the Microbiome, Weight, and Glucoregulation (NI-MWG)
Is Weight Change and Glucoregulation Related to Dietary Intake, the Gut Microbiome or the Interaction Between The Two Variables?
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Research Institute (NRI)
mi
from
Fargo, ND
The Effect of Nutrient Intake on the Microbiome, Weight, and Glucoregulation (NI-MWG)
Is Weight Change and Glucoregulation Related to Dietary Intake, the Gut Microbiome or the Interaction Between The Two Variables?
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Research Institute (NRI)
mi
from
Fargo, ND
Click here to add this to my saved trials
Beverage Consumption and Fine Motor Control
The Effect of Low Calorie Sweetener Consumption on Body Weight, Body Composition, Appetite, and Energy Intake
Status: Enrolling
Updated:  12/31/1969
Purdue University
mi
from
West Lafayette, IN
Beverage Consumption and Fine Motor Control
The Effect of Low Calorie Sweetener Consumption on Body Weight, Body Composition, Appetite, and Energy Intake
Status: Enrolling
Updated: 12/31/1969
Purdue University
mi
from
West Lafayette, IN
Click here to add this to my saved trials
Cryoablation for Obesity Management
Percutaneous Image Guided Cryoablation of the Vagus Nerve for Management of Mild-Moderate Obesity
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Cryoablation for Obesity Management
Percutaneous Image Guided Cryoablation of the Vagus Nerve for Management of Mild-Moderate Obesity
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cryoablation for Obesity Management
Percutaneous Image Guided Cryoablation of the Vagus Nerve for Management of Mild-Moderate Obesity
Status: Enrolling
Updated:  12/31/1969
Emory St. Joseph's Hospital
mi
from
Atlanta, GA
Cryoablation for Obesity Management
Percutaneous Image Guided Cryoablation of the Vagus Nerve for Management of Mild-Moderate Obesity
Status: Enrolling
Updated: 12/31/1969
Emory St. Joseph's Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cryoablation for Obesity Management
Percutaneous Image Guided Cryoablation of the Vagus Nerve for Management of Mild-Moderate Obesity
Status: Enrolling
Updated:  12/31/1969
Emory Johns Creek Hospital
mi
from
Johns Creek, GA
Cryoablation for Obesity Management
Percutaneous Image Guided Cryoablation of the Vagus Nerve for Management of Mild-Moderate Obesity
Status: Enrolling
Updated: 12/31/1969
Emory Johns Creek Hospital
mi
from
Johns Creek, GA
Click here to add this to my saved trials
Supplemental Calcium in Overweight People
Supplemental Calcium in Overweight Out-Patients
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Supplemental Calcium in Overweight People
Supplemental Calcium in Overweight Out-Patients
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of Betahistine Hydrochloride in Overweight Women
Pilot Study of the Metabolic Effects of Betahistine Hydrochloride in Overweight Women
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Effects of Betahistine Hydrochloride in Overweight Women
Pilot Study of the Metabolic Effects of Betahistine Hydrochloride in Overweight Women
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Stanford Healthy Heart Study
Escalating Proportion of Weight-Loss Maintainers Via Modules Prior to Weight Loss
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Palo Alto, CA
Stanford Healthy Heart Study
Escalating Proportion of Weight-Loss Maintainers Via Modules Prior to Weight Loss
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Small Monetary Incentives to Promote Exercise (Exercise4Good; EX4G)
Using Behavioral Economics to Promote Exercise Among Overweight Inactive Adults
Status: Enrolling
Updated:  12/31/1969
Public Health Building @ 121 South Main St
mi
from
Providence, RI
Small Monetary Incentives to Promote Exercise (Exercise4Good; EX4G)
Using Behavioral Economics to Promote Exercise Among Overweight Inactive Adults
Status: Enrolling
Updated: 12/31/1969
Public Health Building @ 121 South Main St
mi
from
Providence, RI
Click here to add this to my saved trials
Surgical vs. Lifestyle in Obese Older Adults
Comparison of Surgical vs. Lifestyle Weight Treatment in Obese Older Adults
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Surgical vs. Lifestyle in Obese Older Adults
Comparison of Surgical vs. Lifestyle Weight Treatment in Obese Older Adults
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
Status: Enrolling
Updated:  12/31/1969
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
Status: Enrolling
Updated: 12/31/1969
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability
POWERSforID: Personalized Online Weight and Exercise Response System for Adults With Intellectual Disability
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability
POWERSforID: Personalized Online Weight and Exercise Response System for Adults With Intellectual Disability
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
MOWI Qualitative Assessment
Mobile Health Obesity Wellness Intervention in Rural Older Adults (MOWI): Qualitative Assessment
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
MOWI Qualitative Assessment
Mobile Health Obesity Wellness Intervention in Rural Older Adults (MOWI): Qualitative Assessment
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Diet, Insulin Sensitivity, and Postprandial Metabolism
A Randomized, Controlled Trial on Diet, Insulin Sensitivity, and Postprandial Metabolism
Status: Enrolling
Updated:  12/31/1969
Physicians Committee for Responsible Medicine
mi
from
Washington,
Diet, Insulin Sensitivity, and Postprandial Metabolism
A Randomized, Controlled Trial on Diet, Insulin Sensitivity, and Postprandial Metabolism
Status: Enrolling
Updated: 12/31/1969
Physicians Committee for Responsible Medicine
mi
from
Washington,
Click here to add this to my saved trials
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Carmichael, CA
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Carmichael, CA
Click here to add this to my saved trials
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Roseville, CA
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Roseville, CA
Click here to add this to my saved trials
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated:  12/31/1969
Novartis
mi
from
Denver, CO
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated: 12/31/1969
Novartis
mi
from
Denver, CO
Click here to add this to my saved trials
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Golden, CO
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Golden, CO
Click here to add this to my saved trials
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Missoula, MT
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Missoula, MT
Click here to add this to my saved trials
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Omaha, NE
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Tacoma, WA
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Anniston, AL
A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
A Randomized, Double-blind, Dose-finding Study to Evaluate the Change in Weight After 24 Weeks Treatment With 8 Doses of LIK066 Compared to Placebo in Obese or Overweight Adults, Followed by 24 Weeks Treatment With 2 Doses of LIK066 and Placebo
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Anniston, AL
Click here to add this to my saved trials